Trade Mark Journal No.2026/028 10 July 2026
UK00004405948 23 June 2026 (1,5,42)

International priority date claimed: 23 December 2025
(United States of America)
(99564144)
- Class 1
- Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders.
- Class 5
- Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; Pharmaceutical preparations for the treatment of depression and anxiety.
- Class 42
- Pharmaceutical drug development services.
Cybin Corp.
Representative: Stobbs